BHVI has a successful history of commercialising its technology through our comprehensive internal intellectual property program. The first product sale was in 1998 and products continue to be sold today.
Our success is twofold:
- We understand market needs and structure our research programs accordingly.
- We tailor our invention process to achieve commercial outcomes.
Our normal commercial pathways are below, however, we are open to other commercial opportunities:
- Co-development / R&D collaborations
- Licensing our technology
- Service contracts
1998
ALCON (Formerly CIBA Vision)
Co-development of Focus® Night & Day™ contact lens (first silicone hydrogels material)
1998
2002
CooperVision (Formerly OSI)
Co-development of Biomedics Toric soft contact lens
2002
2009
ALCON
Co-development of AIR OPTIX™ AQUA MULTIFOCAL contact lens
2009
2010
ZEISS
Co-development of MyoVision™ spectacle lens
2010
2017
Mark’ennovy
Licensed EDOF contact lens designs for myopia and presbyopia
SEED Co Ltd
Licensed EDOF contact lens designs for myopia and presbyopia
2017
2018
SynergEyes®
Licensed EDOF contact lens designs for myopia and presbyopia
2018
2019
OCULUS GMBH
Licensed predictive algorithm technology for refractive error management to be used in the Myopia Master® range of ophthalmic equipment
2019
2020
Bausch + Lomb
Exclusive global licensing agreement for myopia control contact lens
2020